BAO PHARMA-B Announces Board Re-election and Appointment of New Chairman

Stock News05-26

BAO PHARMA-B (02659) has announced the results of its board re-election. Dr. Liu Yanjun, Ms. Wang Zheng, and Ms. Li Cui have been re-elected as executive directors for the second-term board. Ms. Lin Jialing, Mr. Diao Junhuan, and Mr. Li Chen have been re-elected as non-executive directors. Additionally, Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen, and Mr. Zhang Senquan have been re-elected as independent non-executive directors.

Following the Annual General Meeting, at the first meeting of the second-term board, Dr. Liu Yanjun was appointed as Chairman of the Board. His term as Chairman will commence on May 26, 2026, and will last for three years, concluding with the end of the second-term board's tenure.

Separately, Mr. Sun Yuhua was elected as an employee representative director at the company's staff congress held on May 26, 2026. Mr. Sun currently serves as the company's Deputy General Manager.

With the board's re-election at the AGM, the tenure of the first-term board has concluded. Consequently, Mr. Tan Jingwei, an executive director of the first-term board, has stepped down from his role as executive director and from the board entirely, effective May 26, 2026, to dedicate more time to personal matters.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1154281893?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 22:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1154281893","market":"nz","top_or_hot":-1,"title":"BAO PHARMA-B Announces Board Re-election and Appointment of New Chairman","media":"Stock News","content":"<p>BAO PHARMA-B (02659) has announced the results of its board re-election. Dr. Liu Yanjun, Ms. Wang Zheng, and Ms. Li Cui have been re-elected as executive directors for the second-term board. Ms. Lin Jialing, Mr. Diao Junhuan, and Mr. Li Chen have been re-elected as non-executive directors. Additionally, Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen, and Mr. Zhang Senquan have been re-elected as independent non-executive directors.</p>\n<p>Following the Annual General Meeting, at the first meeting of the second-term board, Dr. Liu Yanjun was appointed as Chairman of the Board. His term as Chairman will commence on May 26, 2026, and will last for three years, concluding with the end of the second-term board's tenure.</p>\n<p>Separately, Mr. Sun Yuhua was elected as an employee representative director at the company's staff congress held on May 26, 2026. Mr. Sun currently serves as the company's Deputy General Manager.</p>\n<p>With the board's re-election at the AGM, the tenure of the first-term board has concluded. Consequently, Mr. Tan Jingwei, an executive director of the first-term board, has stepped down from his role as executive director and from the board entirely, effective May 26, 2026, to dedicate more time to personal matters.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BAO PHARMA-B Announces Board Re-election and Appointment of New Chairman</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBAO PHARMA-B Announces Board Re-election and Appointment of New Chairman\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-26 22:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BAO PHARMA-B (02659) has announced the results of its board re-election. Dr. Liu Yanjun, Ms. Wang Zheng, and Ms. Li Cui have been re-elected as executive directors for the second-term board. Ms. Lin Jialing, Mr. Diao Junhuan, and Mr. Li Chen have been re-elected as non-executive directors. Additionally, Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen, and Mr. Zhang Senquan have been re-elected as independent non-executive directors.</p>\n<p>Following the Annual General Meeting, at the first meeting of the second-term board, Dr. Liu Yanjun was appointed as Chairman of the Board. His term as Chairman will commence on May 26, 2026, and will last for three years, concluding with the end of the second-term board's tenure.</p>\n<p>Separately, Mr. Sun Yuhua was elected as an employee representative director at the company's staff congress held on May 26, 2026. Mr. Sun currently serves as the company's Deputy General Manager.</p>\n<p>With the board's re-election at the AGM, the tenure of the first-term board has concluded. Consequently, Mr. Tan Jingwei, an executive director of the first-term board, has stepped down from his role as executive director and from the board entirely, effective May 26, 2026, to dedicate more time to personal matters.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1154281893","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1154281893","pubTimestamp":1779804025,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"BAO PHARMA-B (02659) has announced the results of its board re-election. Dr. Liu Yanjun, Ms. Wang Zheng, and Ms. Li Cui have been re-elected as executive directors for the second-term board. Ms. Lin...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02659":"宝济药业-B"},"translate_title":"宝药业-B宣布董事会重选及委任新主席","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"BAO PHARMA-B (02659) has announced the results of its board re-election. Dr. Liu Yanjun, Ms. Wang Zheng, and Ms. Li Cui have been re-elected as executive directors for the second-term board. Ms. Lin Jialing, Mr. Diao Junhuan, and Mr. Li Chen have been re-elected as non-executive directors. Additionally, Mr. Cai Zhongxi, Dr. Zeng Fanyi, Dr. Ju Dianwen, and Mr. Zhang Senquan have been re-elected as independent non-executive directors.\nFollowing the Annual General Meeting, at the first meeting of the second-term board, Dr. Liu Yanjun was appointed as Chairman of the Board. His term as Chairman will commence on May 26, 2026, and will last for three years, concluding with the end of the second-term board's tenure.\nSeparately, Mr. Sun Yuhua was elected as an employee representative director at the company's staff congress held on May 26, 2026. Mr. Sun currently serves as the company's Deputy General Manager.\nWith the board's re-election at the AGM, the tenure of the first-term board has concluded. Consequently, Mr. Tan Jingwei, an executive director of the first-term board, has stepped down from his role as executive director and from the board entirely, effective May 26, 2026, to dedicate more time to personal matters.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1154281893","isCrawlerRequest":true}